Bessemer Group Inc Gritstone Bio, Inc. Transaction History

Bessemer Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$8.13 - $10.2 $251,558 - $315,608	-30,942 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$4.07 - $27.11 $125,933 - $838,837	30,942 New	30,942 $291,000
Q3 2020 Nov 12, 2020	SELL	$2.63 - $8.09 $214,608 - $660,144	-81,600 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$5.69 - $8.17 $464,304 - $666,672	81,600 New	81,600 $542,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.